Literature DB >> 30106842

Stage-specific incidence trends of melanoma in an English region, 1996-2015: longitudinal analyses of population-based data.

Annie Herbert1, Minjoung M Koo1, Matthew E Barclay2,3, David C Greenberg2, Gary A Abel4, Nick J Levell5, Georgios Lyratzopoulos1,2,3.   

Abstract

The aim of this study was to examine temporal trends in overall and stage-specific incidence of melanoma. Using population-based data on patients diagnosed with melanoma in East Anglia, England, 1996-2015, we estimated age-standardized time trends in annual incidence rates for each stage at diagnosis. Negative binomial regression was used to model trends over time adjusted for sex, age group and deprivation, and to subsequently examine variation in stage-specific trends by sex and age group. The age-standardized incidence increased from 14 to 29 cases/100 000 persons (i.e. 4% annually). Increasing incidence was apparent across all stages but was steepest for stage I [adjusted annual increase: 5%, 95% confidence interval (CI): 5-6%, and more gradual for stage II-IV disease (stage II: 3%, 95% CI: 2-4%; stage III/IV: 2%, 95% CI: 1-3%)]. Stage II-IV increase was apparent in men across age groups and in women aged 50 years or older. Increases in incidence were steeper in those aged 70 years or older, and in men. The findings suggest that both a genuine increase in the incidence of consequential illness and a degree of overdiagnosis may be responsible for the observed increasing incidence trends in melanoma in our population during the study period. They also suggest the potentially lower effectiveness of public health awareness campaigns in men and older people.

Entities:  

Mesh:

Year:  2020        PMID: 30106842      PMCID: PMC6330074          DOI: 10.1097/CMR.0000000000000489

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.199


  26 in total

1.  The Growing Burden of Invasive Melanoma: Projections of Incidence Rates and Numbers of New Cases in Six Susceptible Populations through 2031.

Authors:  David C Whiteman; Adele C Green; Catherine M Olsen
Journal:  J Invest Dermatol       Date:  2016-02-20       Impact factor: 8.551

2.  Skin biopsy rates and incidence of melanoma: population based ecological study.

Authors:  H Gilbert Welch; Steven Woloshin; Lisa M Schwartz
Journal:  BMJ       Date:  2005-08-04

3.  Single versus multiple primary melanomas: old questions and new answers.

Authors:  Charlotte Hwa; Leah S Price; Ilana Belitskaya-Levy; Michelle W Ma; Richard L Shapiro; Russell S Berman; Hideko Kamino; Farbod Darvishian; Iman Osman; Jennifer A Stein
Journal:  Cancer       Date:  2012-01-13       Impact factor: 6.860

4.  Survival outcomes in patients with multiple primary melanomas.

Authors:  C J Rowe; M H Law; J M Palmer; S MacGregor; N K Hayward; K Khosrotehrani
Journal:  J Eur Acad Dermatol Venereol       Date:  2015-04-10       Impact factor: 6.166

5.  Melanoma epidemic: a midsummer night's dream?

Authors:  N J Levell; C C Beattie; S Shuster; D C Greenberg
Journal:  Br J Dermatol       Date:  2009-06-09       Impact factor: 9.302

Review 6.  Epidemiology of melanoma and nonmelanoma skin cancer--the role of sunlight.

Authors:  Ulrike Leiter; Claus Garbe
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

7.  Epidemiology of melanoma: is it still epidemic? What is the role of the sun, sunbeds, Vit D, betablocks, and others?

Authors:  Vincenzo De Giorgi; Alessia Gori; Marta Grazzini; Susanna Rossari; Teresa Oranges; Anna Sara Longo; Torello Lotti; Sara Gandini
Journal:  Dermatol Ther       Date:  2012 Sep-Oct       Impact factor: 2.851

8.  Disparities in melanoma incidence and mortality in South-Eastern Europe: Increasing incidence and divergent mortality patterns. Is progress around the corner?

Authors:  Jelena Barbaric; Mario Sekerija; Dominic Agius; Daniela Coza; Nadya Dimitrova; Anna Demetriou; Chakameh Safaei Diba; Sultan Eser; Zivana Gavric; Maja Primic-Zakelj; Snezana Zivkovic; Miroslav Zvolsky; Freddie Bray; Jan Willem Coebergh; Ariana Znaor
Journal:  Eur J Cancer       Date:  2016-01-09       Impact factor: 9.162

9.  Melanoma Thickness and Survival Trends in the United States, 1989 to 2009.

Authors:  Waqas R Shaikh; Stephen W Dusza; Martin A Weinstock; Susan A Oliveria; Alan C Geller; Allan C Halpern
Journal:  J Natl Cancer Inst       Date:  2015-11-12       Impact factor: 13.506

10.  13. Cancers attributable to solar (ultraviolet) radiation exposure in the UK in 2010.

Authors:  D M Parkin; D Mesher; P Sasieni
Journal:  Br J Cancer       Date:  2011-12-06       Impact factor: 7.640

View more
  8 in total

1.  Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040.

Authors:  Melina Arnold; Deependra Singh; Mathieu Laversanne; Jerome Vignat; Salvatore Vaccarella; Filip Meheus; Anne E Cust; Esther de Vries; David C Whiteman; Freddie Bray
Journal:  JAMA Dermatol       Date:  2022-05-01       Impact factor: 11.816

2.  Stage-specific incidence trends of renal cancers in the East of England, 1999-2016.

Authors:  Annie Herbert; Matthew E Barclay; Minjoung M Koo; Brian Rous; David C Greenberg; Gary Abel; Georgios Lyratzopoulos
Journal:  Cancer Epidemiol       Date:  2021-01-22       Impact factor: 2.984

3.  Trends in Incidence and Mortality of Skin Melanoma in Lithuania 1991-2015.

Authors:  Audrius Dulskas; Dovile Cerkauskaite; Ieva Vincerževskiene; Vincas Urbonas
Journal:  Int J Environ Res Public Health       Date:  2021-04-15       Impact factor: 3.390

4.  Demographics, Pattern of Care, and Outcome Analysis of Malignant Melanomas - Experience From a Tertiary Cancer Centre in India.

Authors:  Jyoti Bajpai; George Abraham; Avanish P Saklani; Anshul Agarwal; Sashanka Das; Ambarish Chatterjee; Akhil Kapoor; Prathyusha Eaga; Pradip Kumar Mondal; Arun Chandrasekharan; Prabhat Ghanshyam Bhargava; Sujay Srinivas; Siddharth Turkar; Bharat Rekhi; Nehal Khanna; Amit Kumar Janu; Munita Bal; Vikas Sureshchand Ostwal; Anant Ramaswamy; Jitender Rohila; Ashwin L Desouza; Amrita Guha; Rajiv Kumar; Nandini Sharrel Menon; Sushmita Rath; Vijay Maruti Patil; Vanita Maria Noronha; Amit Prakashchandra Joshi; Siddhartha Laskar; Venkatesh Rangarajan; Kumar Prabhash; Sudeep Gupta; Shripad Banavali
Journal:  Front Oncol       Date:  2021-09-08       Impact factor: 6.244

5.  Using a 31-Gene Expression Profile Test to Stratify Patients with Stage I-II Cutaneous Melanoma According to Recurrence Risk: Update to a Prospective, Multicenter Study.

Authors:  Sebastian Podlipnik; Aram Boada; Jose L López-Estebaranz; Manuel M Martín-González; Pedro Redondo; Brian Martin; Ann P Quick; Christine N Bailey; Sarah J Kurley; Robert W Cook; Susana Puig
Journal:  Cancers (Basel)       Date:  2022-02-19       Impact factor: 6.639

6.  Risk Stratification and Clinical Characteristics of Patients with Late Recurrence of Melanoma (>10 Years).

Authors:  Robin Reschke; Konstantin Dumann; Mirjana Ziemer
Journal:  J Clin Med       Date:  2022-04-05       Impact factor: 4.964

7.  Clinical performance indicators for monitoring the management of cutaneous melanoma: a population-based perspective.

Authors:  Alessandra Buja; Massimo Rugge; Giuseppe De Luca; Manuel Zorzi; Claudia Cozzolino; Antonella Vecchiato; Paolo Del Fiore; Saveria Tropea; Alberto Bortolami; Patrizia Benini; Carlo Riccardo Rossi; Simone Mocellin
Journal:  Melanoma Res       Date:  2022-07-19       Impact factor: 3.199

Review 8.  Epidemiology and survival outcomes in stages II and III cutaneous melanoma: a systematic review.

Authors:  Rachael Miller; Sophie Walker; Irene Shui; Agnes Brandtmüller; Kevin Cadwell; Emilie Scherrer
Journal:  Melanoma Manag       Date:  2020-03-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.